Madrigal Pharmaceuticals (MDGL) PT Raised to $82 at Roth Capital
Tweet Send to a Friend
Roth Capital raised its price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $82.00 (from $62.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
